When the immune system has become your enemy

A unique treatment for introducing immunological tolerance

Idogen develops tolerogenic cell therapies to prevent the patient’s immune system from attacking biological agents, transplanted organs or the body’s own cells or tissues.

Link to: Idogen´s technologyLink to: Stock informationLink to: Upcoming eventsLink to: Presentations and Interviews

Idogen´s technology enables development of tolerogenic cell therapy in a number of areas

Read more about our therapeutic areas:

Idogen develops tolerogenic cell therapy

Individualised treatment for each patient

SUBSCRIBE

Which information would you like to subscribe to?

TWITTER

It’s time for some renewal that reflects the development Idogen made last year! Today we are changing to a new logo, and with our new website, hopefully, it will be even easier to access our research and progress. https://www.idogen.com

Det är dags för lite förnyelse som speglar den utveckling Idogen gjort det senaste året! Idag byter vi till en ny logga, och med vår nya webbplats blir det förhoppningsvis ännu lättare att ta del av vår forskning och våra framsteg. https://www.idogen.com

Load More...

Idogen AB   |   Medicon Village   |   Scheelevägen 2   |   SE-223 81 Lund   |  Sweden   |  E-mail: info at idogen dot com

This project has received funding from the European Union’s Horizon 2020 research and innovation programme.